- Bristol Myers, Bain Capital form new company to develop immunology drugs Reuters
- Bristol Myers Squibb and Bain Capital Form New Immunology Company The Wall Street Journal
- Bristol Myers sends five immunology assets to new $300M biotech led by Bain Capital Endpoints News
- Bristol Myers, Bain Capital form a new biopharmaceutical company Seeking Alpha
- Bristol Myers Squibb and Bain Capital Create New Company citybiz
Source link
